RADIANCE-HTN-TRIO: what does this mean for the treatment of hypertension? - EuroPCR 2021

(9:18)

RADIANCE-HTN TRIO: key takeaways and implications for the treatment of hypertension - EuroPCR 2021

(10:17)

RADIANCE-HTN TRIO - Primary Analysis and Result

(13:2)

TCT 2021: RADIANCE-HTN: 6Mo Outcomes of RDN Vs a Sham Procedure for Resistant Hypertension

(2:14)

A review of the RADIANCE-HTN global clinical trial programme: a focus on the TRIO cohort - #EuroPCR

(38:23)

PCR e-Course 2020: Crossover Results From The RADIANCE-HTN SOLO Trial — Dr Ajay J Kirtane

(5:48)

ACC 2019: RADIANCE-HTN-SOLO - Dr Ajay Kirtane

(3:18)

Ultrasound renal denervation: RADIANCE-HTN SOLO results - EuroPCR 2019

(8:11)

The Radiance HTN-SOLO results - A sound choice for Renal Denervation

(13:20)

RADIANCE-HTN SOLO: primary outcomes of renal denervation - session webcast

(59:5)

EuroPCR 2018: RADIANCE-HTN SOLO - Renal Denervation - Dr Laura Mauri

(4:35)

ACC 2021 Discussion: The Randomized Sham-controlled RADIANCE-HTN TRIO Trial

(16:21)

A Review of RADIANCE-HTN TRIO cohort

(59:56)

Study Update of the ReCor Medical Paradise System in Clinical Hypertension (RADIANCE-HTN)

(1:30)

Crossover results from the RADIANCE-HTN SOLO trial

(7:29)

EuroPCR 22: Patient-Level Pooled Analysis of Ultrasound RDN in radiance-HTN SOLO \u0026 Trio

(5:11)

Latest evidence from the RADIANCE-HTN trial and the path to clinical adoption - PCR e-Course 2020

(15:59)

Ajay Kirtane, TCT 2022: Ultrasound renal denervation for uncontrolled hypertension, RADIANCE II

(3:54)

RADIANCE signals a bright future for renal denervation - EuroPCR 2018

(5:50)

TCT 22: RADIANCE II Pivotal Trial: Paradise Renal Denervation System in Pts With Hypertension

(5:13)